Adults who need to track their blood pressure (BP) to find out if they have hypertension prefer to do it
Read more
Home »
Empagliflozin’s HFpEF Efficacy Catalyzes Redefinition of HF
Groundbreaking results from the EMPEROR-Preserved trial did more than establish for the first time that a drug, empagliflozin, has clearly
Read more
Mediterranean Diet Slows Progression of Atherosclerosis in CHD
For patients with coronary heart disease (CHD), following a Mediterranean diet is more effective in reducing progression of atherosclerosis than
Read more
Statin Safety, Low Muscle-Pain Risk Upheld in ‘Reassuring’ Study
Statins are associated with a low risk of adverse events in patients without a history of heart disease but the
Read more
Apple Lists More Products That Could Interfere With Cardiac Devices
Apple has expanded the number of its products that should be kept “a safe distance” from cardiac devices because of
Read more
AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides
TUESDAY, Nov. 13, 2018 — Icosapent ethyl is associated with a reduced risk for ischemic events among patients with elevated
Read more